Eagle Pharmaceuticals

stop light green
Pharma

Eagle's Pemfexy catches up with Lilly's Alimta in lung cancer

The FDA has blessed Eagle's Pemfexy with a fifth NSCLC indication, this one in combo with Merck’s Keytruda and platinum chemotherapy.
Kevin Dunleavy Dec 19, 2022 10:25am
A gavel in the foreground with the scale of justice in the background

Endo's patent claims against Eagle don't hold up, again

Aug 19, 2022 11:20am
FDA Building

Treanda copycat delay shows FDA trapped by orphan drug rules

Feb 26, 2019 12:17pm
FDA sign

Alabama compounder slapped with FDA warning letter

Oct 25, 2016 7:48am